Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: A case report

European Journal of Heart Failure

Volumn 12, Issue 1, 2010, Pages 94-97

  Haruki, Shintaro ^a   Minami, Yuichiro ^a   Kajimoto, Katsuya ^a   Yashiro, Bun ^a   Suzuki, Tsuyoshi ^a   Kawana, Masatoshi ^a   Hagiwara, Nobuhisa ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Disopyramide; Dual chamber pacing; Hypertrophic cardiomyopathy

Indexed keywords

ATENOLOL; DISOPYRAMIDE;

AGED; ANAMNESIS; AORTA PRESSURE; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PACING; HEART VENTRICLE PRESSURE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MONOTHERAPY; PRIORITY JOURNAL; SINUS BRADYCARDIA; SYSTOLIC HEART MURMUR;

AGED; ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; COMBINED MODALITY THERAPY; DISOPYRAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 72649089332     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp166     Document Type: Article

References (14)

1. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303. (Pubitemid 36119984)
2. Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, RossJ Jr. Effects ofbeta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation 1964;29:84-98.
3. Rosing DR, Condit JR, Maron BJ, Kent KM, Leon MB, Bonow RO, Lipson LC, Epstein SE. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol 1981;48:545-553.
4. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;45:1251-1258.
5. Pollick C. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration. Am J Cardiol 1988;62:1252-1255. (Pubitemid 18276996)
6. Pollick C, Kimball B, Henderson M, Wigle ED. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 1988;62:1248-1251. (Pubitemid 18276995)
7. Sherrid M, Delia E, Dwyer E. Oral disopyramide therapy for obstructive hyper-trophic cardiomyopathy. Am J Cardiol 1988;62:1085-1088.
8. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
9. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik AJ, Spencer WH. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hyper-trophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
10. FananapazirL, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreaveyD.Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopa-thy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-2742.
11. Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N, Chojnowska L, Guize L, Gras D, Jeanrenaud X, Ryden L. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 1997;18:1249-1256. (Pubitemid 27332144)
12. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999;99: 2927-2933.
13. Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Allison TG, Tajik AJ. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-441.
14. Minami Y, Kajimoto K, Kawana M, Hagiwara N, Sherrid MV. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopa-thy. Int J Cardiol; doi:10.1016/j.ijcard.2008.11.088. Published online ahead of print 20 December 2008.